Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
808.00    -10.00 (-1.22%)
Bid:
811.00
Ask:
813.00
Spread: 2.00 (0.247%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement

8 May 2018 12:00

RNS Number : 3728N
Savills PLC
08 May 2018
 

 

8 May 2018

SAVILLS PLC

("Savills" or "the Company")

 

AGM Statement

 

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 2.30pm, 33 Margaret Street, London, W1G 0JD, and provides the following AGM statement.

 

During the year to date Savills has traded in line with our expectations. Globally, our transaction businesses have continued to maintain a strong market share although, as anticipated, there is a tendency for transactions to take longer to complete. Our Consultancy and Property Management businesses have continued to perform well.

 

In the UK, trading was slightly ahead of our expectations principally down to strong performances in Central London Commercial transactions and from our portfolio of Less Transactional businesses including property management. UK commercial markets more generally are seeing greater uncertainty and a relative lack of stock which has reduced transaction levels. The residential market had a very quiet start to the year, however we have seen stronger levels of activity since the middle of March.

 

In Asia Pacific, Savills has had a good start to the year, despite adverse currency movements. Hong Kong and Korea have performed well offsetting slight declines in activity in Australia and Japan.

 

In the US, Savills Studley has had a slower start to the year than initially anticipated with the timing of transactions resulting in weaker volumes in New York and Washington. This offset stronger growth in other markets, notably California and New Jersey. Overall we have a good pipeline of instructions. 

 

In Continental Europe, to date we have traded marginally behind our expectations, again due to delays in transactions, with stronger than anticipated performances in Germany, Netherlands and Sweden, largely offsetting slower performances in France and Poland and the continuing start-up costs in the Czech Republic. In Spain, the integration of Aguirre Newman has gone well and generally across the European business, pipeline activity is solid.

 

Savills Investment Management has performed as expected with a good pipeline of product launches.

 

Whilst we have started the year as expected, typically the first four months represent a disproportionately small element of the expected outturn for the full year. Consequently, at this stage in the year, we continue to anticipate overall performance to be in line with our expectations.

 

 

For further information, contact:

 

Savills 020 7409 8934

Jeremy Helsby, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

Peter Hewer

Will Palfreyman

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMLLFEIELITIIT
Date   Source Headline
1st Jun 202611:29 amRNSTotal Voting Rights
22nd May 202610:09 amRNSDirector/PDMR Shareholding
14th May 202612:41 pmRNSResult of AGM
13th May 20264:16 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Statement
12th May 20263:41 pmRNSDirector/PDMR Shareholding
7th May 20263:39 pmRNSDirector Declaration
29th Apr 20263:04 pmRNSReplacement - Director/PDMR Shareholding
29th Apr 20261:23 pmRNSDirector/PDMR Shareholding
28th Apr 20261:58 pmRNSDirector/PDMR Shareholding
13th Apr 20265:24 pmRNSHolding(s) in Company
13th Apr 20262:10 pmRNSDirector/PDMR Shareholding
7th Apr 20264:03 pmRNSAnnual Report and AGM Notice
1st Apr 202610:00 amRNSTotal Voting Rights
31st Mar 202612:55 pmRNSDirector/PDMR Shareholding
26th Mar 20268:57 amRNSDirector/PDMR Shareholding
24th Mar 202611:02 amRNSDirector/PDMR Shareholding
23rd Mar 20269:27 amRNSDirector/PDMR Shareholding
18th Mar 20263:47 pmRNSDirector/PDMR Shareholding
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
13th Mar 20261:34 pmRNSDirector/PDMR Shareholding
13th Mar 20261:32 pmRNSDirector/PDMR Shareholding
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:08 amRNSFinal Results
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
5th Mar 20265:00 pmRNSHolding(s) in Company
2nd Mar 20269:11 amRNSTotal Voting Rights
25th Feb 202611:14 amRNSHolding(s) in Company
11th Feb 20264:07 pmRNSDirector/PDMR Shareholding
4th Feb 20265:29 pmRNSHolding(s) in Company
2nd Feb 20265:32 pmRNSTotal Voting Rights
19th Jan 20268:30 amRNSDirectorship change
15th Jan 20267:00 amRNSYear End Trading Update
13th Jan 20265:40 pmRNSDirector/PDMR Shareholding
13th Jan 202612:59 pmRNSHolding(s) in Company
2nd Jan 20263:00 pmRNSTotal Voting Rights
11th Dec 20252:00 pmRNSDirector/PDMR Shareholding
1st Dec 20259:49 amRNSTotal Voting Rights
11th Nov 20254:58 pmRNSDirector/PDMR Shareholding
3rd Nov 202512:32 pmRNSTotal Voting Rights
13th Oct 20251:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.